Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study
Author: Laurito, TL
Santagada, V
Caliendo, G
Oliveira, CH
Barrientos-Astigarraga, RE
De Nucci, G
Abstract: A rapid, sensitive and specific method to quantify nevirapine in human plasma using dibenzepine as the internal standard (IS) was developed and validated. The method employed a liquid-liquid extraction. The analyte and the IS were chromatographed on a C-18 analytical column, (150 x 4.6 mm i.d. 4 mum) and analyzed by tandem mass spectrometry in the multiple reaction monitoring mode. The method had a chromatographic run time of 5.0 min and a linear calibration curve over the range 10-5000 ng ml(-1) (r(2) > 0.9970). The between-run precision, based on the relative standard deviation for replicate quality controls was 1.3% (30 ng ml(-1)), 2.8% (300 ng ml(-1)) and 3.6% (3000 ng ml(-1)). The between-run accuracy was 4.0, 7.0 and 6.2% for the above-mentioned concentrations, respectively. This method was employed in a bioequivalence study of two nevirapine tablet formulations (Nevirapina from Far-Manguinhos, Brazil, as a test formulation, and Viramune from Boehringer Ingelheim do Brasil Quimica e Farmaceutica, as a reference formulation) in 25 healthy volunteers of both sexes who received a single 200 mg dose of each formulation. The study was conducted using an open, randomized, two-period crossover design with a 3 week washout interval. The 90% confidence interval (CI) of the individual ratio geometric mean for Nevirapina/Viramune was 96.4-104.5% for AUC((0-last)), 91.4-105.1% for AUC((0-infinity)) and 95.3-111.6% for C-max (AUC = area under the curve; C-max = peak plasma concentration). Since both 90% CI for AUC((0-last)) and AUC((0-infinity)) and C-max were included in the 80-125% interval proposed by the US Food and Drug Administration, Nevirapina was considered bioequivalent to Viramune according to both the rate and extent of absorption. Copyright (C) 2002 John Wiley Sons, Ltd.
Subject: liquid chromatography/tandem mass spectrometry
high-performance liquid chromatography
Country: Inglaterra
Editor: John Wiley & Sons Ltd
Citation: Journal Of Mass Spectrometry. John Wiley & Sons Ltd, v. 37, n. 4, n. 434, n. 441, 2002.
Rights: fechado
Identifier DOI: 10.1002/jms.300
Date Issue: 2002
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000175050700009.pdf156.41 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.